Nezitic
6 minutes ago
Address Updated:
🔴 208 East 51 Street, Suite 112, New York, NY, 10022, United States
🟢 1159 2nd Avenue, Ste 454, New York, NY, 10065, United States
IanFromSI
19 minutes ago
Revance Therapeutics (RVNC) generated significant revenue from both Daxxify and its partnership with Teoxane’s RHA product line in 2024. In Q2 2024, revenue from Daxxify, primarily in the aesthetics segment, grew by 27% year-over-year, reaching $28.7 million. Additionally, the RHA Collection, which